Evidence map›Paper›PMID 39155527›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Impact of the COVID-19 Pandemic on the Treatment of Cancer Patients at a Hospital in Peru.

Leny Bravo, Karla Vizcarra, Jenny Zavaleta, Kevin J Paez, Zaida Morante, Abel Limache-García, César H Saravia

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Leny BravoEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Perú.
Karla VizcarraEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Perú.
Jenny ZavaletaEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Perú.
Kevin J PaezEscuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Ica, Perú.
Zaida MoranteDepartamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú.
Abel Limache-GarcíaAUNA Ideas, Lima, Perú.
César H SaraviaEscuela de Postgrado, Universidad Cesar Vallejo, Lima, Perú.ORCID 0000-0002-4734-3145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe appearance of the new coronavirus, SARS-CoV-2, in Wuhan - China, in 2019 led to the declaration of a COVID-19 pandemic by the World Health Organization. Peru confirmed its first case on March 6, 2020, prompting a significant change in medical care. PURPOSE: Our objective was to determine the impact of the COVID-19 pandemic on cancer treatment in Peru.

methodsA retrospective analysis of hospital data from the National Institute of Neoplastic Diseases revealed substantial decreases in oncological treatments in 2020 compared to 2019.

resultsOncological treatments involving bone marrow transplantation had a greater impact between the months of April and September, at -100% (p=0.003). However, treatments involving surgery in April (-95% [p≤0.001]), radiotherapy in May (-76% [p=0.002]) and chemotherapy in June (-71% [p≤0.001]) also showed significant impacts. Comparative analysis with international data revealed similar trends in cancer care interruptions in different countries. However, variations in the magnitude of the impact were observed, influenced by regional health policies and the severity of the pandemic.

conclusionsThe findings underscore the challenges cancer care providers face during public health crises, requiring adaptive strategies to ensure continued access to essential treatments. Addressing these challenges requires comprehensive public health responses to mitigate the impact of future crises on cancer care systems.

Indexed as

COVID-19NeoplasmsHumansPandemicsPeruRetrospective StudiesSARS-CoV-2cancer patientcancer treatmentCOVID-19 impactLatin Americapublic health

Identifiers

PMID39155527
PMCPMC11331466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.